Right Upper Quadrant Pain in Abdomen of 60-Year-Old Patient
A 60-year-old woman presents with vague abdominal pain in the right upper quadrant. An ultrasound reveals a gallbladder abnormality. Based on the images from the abdomen MRI, what is the diagnosis?
Pineal Mass Discovered in 2-Year-Old Child
A 2-year-old child is found to have a pineal mass, and a biopsy is performed. What is your diagnosis?
Does Active Surveillance Benefit Patients With Metastatic RCC?
Active surveillance prior to initiating targeted therapy might benefit patients with metastatic renal cell carcinoma, since it delays therapy and toxicities.
Younger Cancer Survivors Reduced Prescription Drug Use for Financial Reasons
Many non-elderly cancer survivors may change their use of prescription drugs, such as skipping doses or requesting cheaper medications, for financial reasons.
Computer-Aided Evaluation of Tumor Response Could Benefit RCC Patients
Computer-assisted tumor objective response evaluations for patients with metastatic renal cell carcinoma can save time and reduce errors.
Dacomitinib Shows Some Early Promise in Advanced Penile Cancers
Dacomitinib induction therapy has shown activity in HPV-negative, locally advanced or metastatic penile squamous cell carcinoma.
Optimizing Outcomes for Patients With Curable Bladder Cancer
This video highlights emerging data on genomic markers of response to neoadjuvant chemotherapy for patients with bladder cancer.
Active Surveillance in Small Renal Masses
In this interview we discuss a new study that looked at the outcomes of patients with small renal masses who were followed with active surveillance.
Site of Cancer Care Affected Outcomes for AYAs With Leukemia
Adolescents and young adults with leukemia experienced inferior outcomes compared with children, especially if they were treated outside of a specialized cancer center.
Genomic Subtyping Could Guide Treatment Decisions for Bladder Cancer
Genomic subtyping of muscle-invasive bladder cancer could inform decisions on when best to use neoadjuvant cisplatin-based chemotherapy, according to a retrospective, non-randomized study.
By clicking Accept, you agree to become a member of the UBM Medica Community.